fropenem has been researched along with Urinary Tract Infections in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T; Azagami, S; Bamba, M; Cho, H; Hojo, H; Jozaki, K; Koizumi, Y; Nakao, A; Nonoyama, M; Ojima, T; Ozaki, A; Sunakawa, K; Yokota, T | 1 |
| Fujimoto, N; Iihara, K; Inatomi, H; Kobayashi, T; Matsumoto, T; Muratani, T; Nishimura, T; Takahashi, K; Yamada, Y | 1 |
| Hiraga, N; Matsumoto, T; Muratani, T; Naito, S | 1 |
| Arata, J; Moritono, S; Saito, A | 1 |
1 trial(s) available for fropenem and Urinary Tract Infections
| Article | Year |
|---|---|
[Faropenem 300 mg 3 times daily versus levofloxacin 100 mg 3 times daily in the treatment of urinary tract infections in patients with neurogenic bladder and/or benign prostatic hypertrophy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactams; Drug Administration Schedule; Female; Humans; Lactams; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatic Hyperplasia; Urinary Bladder, Neurogenic; Urinary Tract Infections | 2002 |
3 other study(ies) available for fropenem and Urinary Tract Infections
| Article | Year |
|---|---|
[Efficacy and safety of faropenem in pediatric patients with bacterial infectious diseases].
Topics: beta-Lactams; Child; Child, Preschool; Dosage Forms; Drug Resistance, Bacterial; Humans; Otitis Media; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes; Treatment Outcome; Urinary Tract Infections | 2008 |
Genetic analysis of faropenem-resistant Enterococcus faecalis in urinary isolates.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Genotype; Humans; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Urinary Tract Infections | 2008 |
[Significant role of penem antibiotics: focused on faropenem (discussion)].
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Clinical Trials as Topic; Drug Resistance, Microbial; Humans; Lactams; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections | 1997 |